Project Details
Description
Pilot field efficacy and safety study (GCP) of LY2605541 insulin for the reduction of hyperglycemia and hyperglycemia-associated signs of diabetes mellitus in cats
| Status | Finished |
|---|---|
| Effective start/end date | 9/15/16 → 11/30/17 |
Funding
- ALCHERABIO, LLC
- ELANCO ANIMAL HEALTH
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.